Population pharmacokinetics of maslinic acid, a triterpene from olives, after intravenous and oral administration in rats
- 22 August 2014
- journal article
- research article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 58 (10) , 1970-1979
Abstract
Scope: Maslinic acid is a bioactive minor component of Olea europaea L. with health‐enhancing activities and no harmful effects. A pharmacokinetic (PK) study was conducted to determine its bioavailability for future studies of maslinic acid in humans.Methods and results: Intravenous (1 mg/kg) and oral (50 mg/kg) administrations to Sprague‐Dawley rats were performed. Blood was obtained several times over 24 h and PKs were analyzed with NONMEM 7.2, applying a population approach. Body weight was included a priori in the model with fixed allometric exponents, based on allometric principles. Plasma concentrations versus time were best characterized by a two‐open compartment model with first‐order absorption and linear elimination. Maslinic acid had a relative rapid oral absorption with a peak concentration after administration at 0.51 h and a bioavailability of 5.13%. Once in bloodstream, it distributed extensively into tissues, since the central and peripheral distribution volumes were 8.41 L/70 kg and 63.6 L/70 kg, respectively. The clearance (8 L/h/70 kg) was related to unaltered renal excretion. The prediction‐corrected visual predictive check confirmed its stability and predictive ability.Conclusion: An allometric population PK model was performed for maslinic acid, which adequately described and predicted plasma concentrations.Keywords
Funding Information
- Generalitat de Catalunya (2009SGR471)
- Ministerio de Ciencia e Innovación, Spain (AGL2009-12866)
This publication has 39 references indexed in Scilit:
- Assessment of the safety of maslinic acid, a bioactive compound from Olea europaeaL.Molecular Nutrition & Food Research, 2012
- Colorectal cancer chemoprevention by trans-resveratrolPharmacological Research, 2012
- Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signallingBritish Journal of Nutrition, 2012
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects ModelsThe AAPS Journal, 2011
- Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathwayMolecular Cancer, 2010
- Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and SolutionsThe AAPS Journal, 2009
- COMMENTARY ON BROWN ET AL.'S “TOWARD A METABOLIC THEORY OF ECOLOGY”Ecology, 2004
- A Size Standard for PharmacokineticsClinical Pharmacokinetics, 1996
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978